Zynerba Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference

Zynerba Pharmaceuticals

DEVON, PA — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) announced that Armando Anido, Chairman and Chief Executive Officer of Zynerba Pharmaceuticals, will present during the H.C. Wainwright BioConnect Conference being held virtually January 10-13, 2022.

A webcast of the presentation will be available on-demand beginning January 10, 2022, at 7:00 a.m. ET under the Events & Webcasts tab of the Investors section of the Zynerba website at www.zynerba.com. An archived replay will be available on the Company’s website following the event for 60 days.

Zynerba Pharmaceuticals is an innovator of pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.